Merck to shutter eight R&D facilities in global restructuring

Driven by a need to cut back after swallowing Schering-Plough while relying more on external development collaborations, Merck today spelled out long-awaited plans to shutter eight R&D centers around the globe, including facilities in Cambridge, MA and Montreal. In a release issued this morning, Merck said it would close research operations in Montreal, Canada; Boxmeer (Nobilon facility only), Oss, and Schaijk, Netherlands; Odense, Denmark; Waltrop, Germany; Newhouse, Scotland; and...